Understanding and preventing risks of opioid use during pregnancy
Official title: Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
Funded at Opalgenix, INC. · NIH-10683849 · Data updated 2026-11-12
This study is looking to help pregnant women with Opioid Use Disorder and their babies by creating a tool that predicts who might face challenges during and after pregnancy, so they can get better support and care.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Opalgenix, INC. NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2023 |
| Award (this year) | $325,239 |
| NIH project number | 1R43DA058430-01 |
| Project ID | NIH-10683849 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include pregnant women with Opioid Use Disorder and their newborns.
✕Less likely to help
Patients who are not pregnant or do not have Opioid Use Disorder may not receive any benefit from this research.
What this research studies
This research focuses on predicting and preventing adverse outcomes for mothers and their children affected by Opioid Use Disorder (OUD) during pregnancy. It aims to develop a risk prediction tool that identifies pregnant women at high risk for relapse and their newborns at risk for Neonatal Opioid Withdrawal Syndrome (NOWS). The study will analyze genetic factors and other variables to create a comprehensive approach to improve treatment and outcomes. By addressing the mental health aspects, such as anxiety and depression, the research seeks to enhance the overall care for these vulnerable populations.
Why it matters
Potential benefit: If successful, this research could lead to better prediction and prevention strategies for mothers with OUD, ultimately improving health outcomes for both mothers and their children.
How similar studies have gone: Previous research has shown that genetic factors can influence treatment outcomes in opioid use, suggesting potential for success in this novel approach.
Where this research is happening
-
Opalgenix, INC.
Indianapolis, United States Active
Researchers
- Principal investigator: Plump, Steven R. — Opalgenix, INC.
- Study coordinator: Plump, Steven R.
Related research
Other NIH-funded projects on the same topics.
-
Big data insights to improve opioid-use disorder treatment during pregnancy
A skilled clinician-researcher is using large health data to understand which FDA-approved meds for opioid use disorder work best for pregnant people and how access to care affects safety and outcomes.
-
Fetal brain health markers in pregnant people exposed to opioids
A study of fetal brain health using baby’s circulating RNA carriers in the blood of pregnant people with opioid exposure to help identify which infants may need early treatment.
-
Comparing safety and effectiveness of opioid-use disorder medicines for pregnant people
This project looks at how different medications for opioid use disorder work for people who are pregnant, aiming to understand which options are safer and more effective for both mom and baby.
-
Comparing treatments for opioid use disorder in pregnant women
This study is looking at how well different medications for opioid use disorder work and how safe they are for pregnant women and their babies, with the goal of finding better ways to support moms-to-be who are dealing with this issue.
-
Understanding Fetal Brain Health in Pregnancies with Opioid Use
This research aims to find ways to predict which babies exposed to opioids during pregnancy might develop Neonatal Abstinence Syndrome (NAS) by looking at tiny particles from the baby's brain in the mother's blood.
-
Improving treatment for pregnant women with opioid use disorder in jails
This study is working to make sure that pregnant women in jail who are dealing with opioid use disorder get the right medication and care they need, so both they and their babies can be healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.